Search Details

Word: panels (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

Until now, only antibiotics have worked against Lyme disease. But a new weapon may be at hand. After a nationwide clinical trial involving some 11,000 people, an advisory panel last week urged the U.S. Food and Drug Administration to approve a novel vaccine developed by SmithKline Beecham under the name Lymerix. The vaccine works when the tick is sucking the victim's blood, launching antibodies against the bacteria even before they've left the tick's gut. Although it took three shots over 12 months to achieve it, the vaccine gave immunity to 90% of the test subjects ages...

Author: /time Magazine | Title: The Ticks Are Back | 6/8/1998 | See Source »

...vaccine is not a panacea, however. "Right now the [immunization] schedule is not really user-friendly," admits Dr. Vijay Sikand of Tufts University School of Medicine, one of the participating physicians. "You have to remember to come back 11 months after the second shot." Nor did the panel recommend, pending further testing, use by pregnant women, people with chronic arthritis or youngsters under 18--a group with one of the highest risks of exposure. So even if the FDA gives Lymerix a quick O.K., it won't be of much help against this summer's tick onslaught...

Author: /time Magazine | Title: The Ticks Are Back | 6/8/1998 | See Source »

...installment of the TIME 100 involves soliciting nominations from our editors and journalists around the world, consulting outside experts and historians, and culling through the millions (yes, literally) of votes you've sent us by mail, e-mail time100@time.com and through our website time.com) We also again convened a panel of luminaries with Charlie Rose as host, which was broadcast on his great PBS show; this one, at the Getty Center in Los Angeles, included Sheryl Crow, Rob Reiner, Anna Deavere Smith, our art critic Robert Hughes and Time Inc.'s editor-in-chief, Norman Pearlstine. Then, in a series...

Author: /time Magazine | Title: Our Second 20: This installment of the TIME 100 was harder | 6/8/1998 | See Source »

...advisory panel last week recommended approval for a new drug, infliximab, to treat Crohn's disease--a painful, chronic inflammation of the gastrointestinal tract. There's no cure for Crohn's, but infliximab, which is administered intravenously, significantly reduces symptoms--sometimes for months at a time. Final approval is expected by this fall...

Author: /time Magazine | Title: Your Health: Jun. 8, 1998 | 6/8/1998 | See Source »

...mail message sent to student leaders,Kovacevich, who is also the UAC co-chair, said thecouncil felt the fairest policy was "to select across-sampling of groups that tend to representextracurricular `niches' on campus." Many ethnicgroups already host their own receptions and wouldbe represented in a panel discussion of minoritygroups, Kovacevich added...

Author: By Georgia N. Alexakis, CRIMSON STAFF WRITER | Title: Personal Politics | 6/4/1998 | See Source »

Previous | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | Next